These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 3792731

  • 1. The myocardial levels of the antiarrhythmic drugs: clinical relevance.
    Ferrari M, Padrini R, Piovan D, Bova S, Moretto R, Cargnelli G.
    G Ital Cardiol; 1986 Aug; 16(8):660-2. PubMed ID: 3792731
    [Abstract] [Full Text] [Related]

  • 2. The importance of pharmacokinetics and pharmacodynamics in the clinical evaluation of antiarrhythmic drugs.
    Kates RE.
    G Ital Cardiol; 1986 Aug; 16(8):675-7. PubMed ID: 3792734
    [Abstract] [Full Text] [Related]

  • 3. Interaction of drug metabolites with the class I antiarrhythmic drug receptor on rat cardiac myocytes.
    Sheldon R, Thakore E, Wilson L, Duff H.
    J Pharmacol Exp Ther; 1994 May; 269(2):477-81. PubMed ID: 8182514
    [Abstract] [Full Text] [Related]

  • 4. [Clinical pharmacology of propafenone].
    Ambrosioni E, Marchesini B.
    G Ital Cardiol; 1984 Apr; 14(4):285-92. PubMed ID: 6735021
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacokinetics and pharmacodynamics of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the dog].
    Kaverina NV, Rodionov AP, Lyskovzev VV, Grigoreva JK, Sulakvelidze MT, Poppe H, Klemm W, Morgenroth U.
    Pharmazie; 1985 Dec; 40(12):869-70. PubMed ID: 3841607
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical application of pharmacokinetics for antiarrhythmic drugs.
    Harrison DC.
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():65-72. PubMed ID: 6803703
    [Abstract] [Full Text] [Related]

  • 9. Determination of the class III antiarrhythmic drugs dronedarone and amiodarone, and their principal metabolites in plasma and myocardium by high-performance liquid chromatography and UV-detection.
    Bolderman RW, Hermans JJ, Maessen JG.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jun 15; 877(18-19):1727-31. PubMed ID: 19427276
    [Abstract] [Full Text] [Related]

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 15; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 11. [Current classification of anti-arrhythmia agents].
    Weirich J, Wenzel W.
    Z Kardiol; 2000 Dec 15; 89 Suppl 3():62-7. PubMed ID: 10810787
    [Abstract] [Full Text] [Related]

  • 12. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF, Bui-Xuan B, Kioueh I, Loufoua J, Frassati D, Timour Q.
    Can J Physiol Pharmacol; 2000 Mar 15; 78(3):208-16. PubMed ID: 10721812
    [Abstract] [Full Text] [Related]

  • 13. Plasma and myocardial tissue concentrations of UM-272 (N,N-dimethylpropranolol) after oral administration in dogs.
    Patterson E, Stetson P, Lucchesi BR.
    J Pharmacol Exp Ther; 1980 Aug 15; 214(2):449-53. PubMed ID: 7391989
    [Abstract] [Full Text] [Related]

  • 14. Plasma level monitoring of antiarrhythmic drugs.
    Kates RE.
    Am J Cardiol; 1983 Sep 22; 52(6):8C-13C. PubMed ID: 6624652
    [Abstract] [Full Text] [Related]

  • 15. Beta-blockers as antiarrhythmic agents.
    Zicha S, Tsuji Y, Shiroshita-Takeshita A, Nattel S.
    Handb Exp Pharmacol; 2006 Sep 22; (171):235-66. PubMed ID: 16610347
    [Abstract] [Full Text] [Related]

  • 16. [Experimental arrhythmia models. Critical study of correlations with arrhythmias observed in clinical practice].
    Dupuis BA, Vincent AC.
    Arch Mal Coeur Vaiss; 1981 Dec 22; 74 Spec No():17-27. PubMed ID: 6803699
    [Abstract] [Full Text] [Related]

  • 17. [Therapeutic strategies in acute myocardial infarction: antiarrhythmic therapy].
    Le Heuzey JY, Copie X, Iliou MC, Guize L.
    Arch Mal Coeur Vaiss; 1998 Apr 22; 91 Spec No 2():39-42. PubMed ID: 9749275
    [Abstract] [Full Text] [Related]

  • 18. Class I antiarrhythmic drugs: allosteric inhibitors of [3H] batrachotoxinin binding to rat cardiac sodium channels.
    Sheldon RS, Duff HJ, Thakore E, Hill RJ.
    J Pharmacol Exp Ther; 1994 Jan 22; 268(1):187-94. PubMed ID: 8301556
    [Abstract] [Full Text] [Related]

  • 19. [Antiarrhythmic agents: current situation].
    Bonhorst D.
    Rev Port Cardiol; 1995 May 22; 14(5):421-9, 362. PubMed ID: 7654403
    [Abstract] [Full Text] [Related]

  • 20. Monitoring blood levels of cardioactive drugs.
    Reddy CP, Dominic J, Surawicz B.
    Cardiovasc Clin; 1980 May 22; 11(1):267-90. PubMed ID: 7002304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.